Abstract
Hepatitis C and HIV/AIDS are among the most significant infectious diseases of our time. Psychiatric patients are often part of the higher risk population to contract these diseases, and patients who have contracted these diseases experience a wide variety of psychiatric problems associated with the underlying infection and with its treatment. The authors provide an overview of these infectious diseases and then describe the varying roles psychiatrists have in caring for these patients in the various settings of their work. The complexity of these patients presents a unique challenge to, and opportunity for, psychiatrists to integrate and coordinate their interventions with those of other medical providers and thereby enhance the patient's cooperation with all aspects of care.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Epstein SA, Meguid AS, Wise TN: Psychiatric aspects of gastroenterology, in Cutting-Edge Medicine: What Psychiatrists Need to Know (Review of Psychiatry, 21). Edited by Stotland NL. Washington, DC, American Psychiatric Publishing, 2002.
Davidson S, Judd F, Jolley D, et al: Risk factors for HIV/AIDS and hepatitis C among chronic mentally ill. The Australian and New Zealand Journal of Psychiatry 35(2):203-209, 2001.
Baker DA: Viral Hepatitis, in Infection Control and Applied Epidemiology. Edited by Olmstead RN. St. Louis, Mosby, 1996.
Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 47(RR-19):1-40, 1998.
Thomas DL: Hepatitis for the new millennium: HCV epidemiology. Monograph 7-10, 1999.
McHutchison JG, Gordon SC, Schiff ER, et al: Interferon alpha2b alone or in combination with Ribavarin as initial treatment for chronic hepatitis C. New England Journal of Medicine 339:1485-1492, 1998.
Centers for Disease Control and Prevention. National Center for HIV, STD, and TB Prevention: HIV/ AIDS Surveillance Report 11(1), 1999.
Robinson MJ, Qaqish RB: Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome. Psychiatric Clinics of North America 25(1):149-175, 2002.
Keefe RH, Hall ML: Managed behavioral health care provider practice patterns: A new item for the public policy agenda. Journal of Health and Social Policy 12(1):11-40, 2000.
Dwight MM, Kowdley KV, Russo JE, et al: Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research 49(5):311-317, 2000.
Yovtcheva SP, Rifai MA, Moles JK, et al: Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 42(5):411-415, 2001.
Goulet JL, Molde SD, Constantino J, et al: Psychiatric comorbidity and the long-term care of people with AIDS. Journal of Urban Health 77(2):213-221, 2000.
Grassi L, Mondardini D, Pavanati M, et al: Suicide probability and psychological morbidity secondary to HIV infection: A control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users. Journal of Affective Disorders 64(92-93):195-202, 2001.
Goldman LS: Medical illness in patients with schizophrenia. The Journal of Clinical Psychiatry 60(Suppl 21):10-15, 1999.
Goff DC, Heckers S, Freudenreich O: Schizophrenia. The Medical Clinics of North America 85(3):663-689, 2001.
Fontana RJ, Hussain KB, Schwartz SM, et al: Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology 36(3):401-407, 2002.
Obhrai J, Hall Y, Anand BS: Assessment of fatigue and psychological disturbances in patients with hepatitis C virus infection. Journal of Clinical Gastroenterology 32(5):413-417, 2001.
Forton DM, Alsop JM, Main J, et al: Evidence for a cerebral effect of hepatitis C virus. Lancet 358(9275):38-39, 2001.
Trask PC, Esper P, Redman B, et al: Psychiatric side effects of interferon therapy: Prevalence, proposed mechanisms, and future directions. Journal of Clinical Oncology 18:2316-2326, 2000.
Sederer LI, Ellison J, Keyes C: Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships. Psychiatric Services 49(9):1197-1202, 1998.
De Jonge P, Huyse FJ, Ruinemans GM, et al: Timing of psychiatric consultations: The impact of social vulnerability and level of psychiatric dysfunction. Psychosomatics 41(6):505-511, 2000.
Fontana RJ: Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. Digestive Diseases 18(3):107-116, 2000.
Dieperink E, Willenbring M, Ho SB: Neuropsychiatric symptoms associated with hepatitis C and interferon alfa: A review. American Journal of Psychiatry 157:867-876, 2000.
Kayser N, Louiz H, Guillin O: Confusion and delirium occurring during interferon-alpha treatment. L'Encephale 27(6):585-587, 2001.
Schafer M, Schmidt F, Amann B, et al: Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. Neuropsychobiology 42 (Suppl. 1):43-45, 2000.
Carney CP, Yates WR, Goerdt CJ, et al: Psychiatrists' and internists' knowledge and attitudes about delivery of clinical preventive medical services. Psychiatric Services 49(12):1594-1600, 1998.
Stiebel V, Schwartz CE: Physicians at the medicine/psychiatric interface: What do internist/psychiatrists do? Psychosomatics 42(5):377-381, 2001.
Ompad DC, Fuller CM, Vlahov D, et al: Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases 35(7):783-788, 2002.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Price, S., Goyette, J. Role of the Psychiatrist in the Care of Patients with Hepatitis C and HIV/AIDS. Psychiatr Q 74, 261–276 (2003). https://doi.org/10.1023/A:1024118605428
Issue Date:
DOI: https://doi.org/10.1023/A:1024118605428